USE OF DUAL H3/M2 ANTAGONISTS IN THE TREATMENT OF COGNITION DEFICIT DISORDERS

Details for Australian Patent Application No. 2002253929 (hide)

Owner SCHERING CORPORATION

Inventors HEY, John, A.; ASLANIAN, Robert, G.

Pub. Number AU-A-2002253929

PCT Pub. Number WO2002/072093

Priority 60/267,352 08.02.01 US

Filing date 6 February 2002

Wipo publication date 24 September 2002

International Classifications

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

A61P 025/28 Drugs for disorders of the nervous system

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002253929

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002253930-AMPLIFIED CANCER GENE WIP1

2002253928-MONETARY BEHAVIOR DETECTION IN A NETWORKED ENVIRONMENT METHOD AND APPARATUS